Effect of Modified Poco-Poco Exercise to Aging Biomarkers in Elderly

NCT ID: NCT07042464

Last Updated: 2025-07-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-20

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Subject with sarcopenia get modified poco-poco exercise program for 12 weeks

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

34 participants (\>60 years) with sarcopenia were modified poco-poco exercises three times weekly for 12 weeks will assessed sarcopenia staging (determined by assessing skeletal muscle index, muscle strength, physical performance) and levels of global DNA methylation and GDF-15.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Geriatrics Rehabilitation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

All research subjects received modified poco-poco exercise program for 12 weeks
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Modified poco-poco exercises

Participants performed modified poco-poco exercises three times weekly for 12 weeks and were assessed, including sarcopenia staging (determined by assessing skeletal muscle index, muscle strength, physical performance) and levels of global DNA methylation and GDF-15

Group Type EXPERIMENTAL

Modified poco-poco exercises

Intervention Type PROCEDURE

Participants performed modified poco-poco exercises three times weekly for 12 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Modified poco-poco exercises

Participants performed modified poco-poco exercises three times weekly for 12 weeks

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age above 60 years old
* Have sarcopenia (based on AWGSOP 2019 criteria)

Exclusion Criteria

* Hearing impairment/loss hindering participants to receive verbal instructions
* Vision impairment/loss hindering participants to receive instructions
* Musculoskeletal impairment or severe joint diseases (i.e. deformity in Osteoarthritis or Rheumatoid Arthritis)
* Participants have been involved in other exercise program
* Severe cardiovascular disease diagnosed by Cardiologist.
* Participants will be excluded from the research if they skip 3 sessions of the program consecutively or skip 5 sessions cumulatively
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universitas Padjadjaran

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Irma Ruslina Defi

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hasan Sadikin General Hospital

Bandung, , Indonesia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Irma Ruslina Defi

Role: CONTACT

+622284288888

Irma Ruslina Defi

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Irma Ruslina Defi

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IKFR.11_2.06.25

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Improving Balance in Frail Elderly
NCT00785746 COMPLETED EARLY_PHASE1